Insider · CIK 0001962333
Ketan Paranjape
Files at SYRA (Syra Health Corp). First filing -, latest -.
Ketan Paranjape files SEC Form 4 as director at SYRA (Syra Health Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ketan Paranjape has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | SYRA Syra Health Corp | AGrant or award Stock Optionsderivative | +43,348 | $0.00 | $0 | 77,821 | Nov 25, 2025 |
| Nov 14, 2024 | SYRA Syra Health Corp | AGrant or award Stock Optionsderivative | +19,303 | $0.00 | $0 | 19,303 | Nov 18, 2024 |
Questions about Ketan Paranjape
Answered from the filings on this page, as of the latest one.
Is Ketan Paranjape buying or selling?
Ketan Paranjape has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ketan Paranjape's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ketan Paranjape has 0.
Where does Ketan Paranjape file Form 4?
Ketan Paranjape has filed Form 4 at SYRA (Syra Health Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.